Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest UNC Lineberger Comprehensive Cancer Center Stories

2014-04-11 23:01:21

In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer patient. Sacramento, Calif. (PRWEB) April 11, 2014 In an effort to reduce cancer health disparities among Asian-Americans, UC Davis Comprehensive Cancer Center now offers individual, in-language education and culturally sensitive materials for every Asian-American cancer...

2014-04-09 16:37:59

The findings shed more light on cancer development and metastasis. The push and pull of physical force can cause profound changes in the behavior of a cell. Two studies from researchers working at the UNC Lineberger Comprehensive Cancer Center reveal how cells respond to mechanical manipulation, a key factor in addressing the underlying causes of cancer and other diseases. The studies, published in Nature Cell Biology and the Journal of Immunology, have their roots in a longtime...

2014-03-31 10:00:45

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging. Researchers measured the level of p16, a protein that causes cellular aging, in the blood of 33 women over the age of 50 who had undergone chemotherapy for curable breast...

2014-03-27 08:35:19

Robust antitumor activity of G1's novel CDK4/6 inhibitors to be highlighted in poster on April 7 CHAPEL HILL, N.C., March 27, 2014 /PRNewswire/ -- G1 Therapeutics, Inc., a privately held pharmaceutical company that focuses on the discovery and development of novel small molecules for use in cancer therapy and biodefense applications, today announced that it will reveal new data on its novel, potent and selective cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors during a poster...

2014-03-20 23:01:42

Florida Hospital Tampa will feature clinical experts in the field of cancer on Tuesday, March 25th to educate the community on the latest information in cancer prevention, treatment, support and therapy. Tampa, Fl (PRWEB) March 20, 2014 Florida Hospital Tampa is hosting “A Cancer Symposium” with a focus on the three big c’s- breast, GI, and lung cancers to educate the community on prevention, treatment, support and therapy. This event is free to the public and will take place at...

2013-12-16 20:21:22

SALT LAKE CITY, Dec. 16, 2013 /PRNewswire/ -- The PAM50 breast cancer signature developed at the University of Utah and Huntsman Cancer Institute received FDA approval and will launch at ARUP Laboratories in Salt Lake City. The test utilizes gene expression data from 50 genes weighted together with clinical variables to generate a risk category and numerical score to assess a patient's risk of distant recurrence at ten years in postmenopausal women with node-negative (Stage I or II)...

2013-10-25 23:21:20

4th Annual Ebix Charity Challenge Returns to Isner’s Hometown of Greensboro, N.C. on December 7, 2013 Greensboro, NC (PRWEB) October 25, 2013 America’s No. 1 tennis player, John Isner, announced today that his annual charity event, the Ebix Charity Challenge, will return to his hometown of Greensboro, North Carolina on December 7, 2013. All proceeds from the 4th Annual Ebix Charity Challenge will again benefit the UNC Lineberger Comprehensive Cancer Center, which is where Isner’s...

2013-10-22 08:33:44

DURHAM, N.C., Oct. 22, 2013 /PRNewswire/ -- CureCancerStarter.org, one of the first websites to connect cancer patients, their friends and family to cancer researchers, launched today. (Photo: http://photos.prnewswire.com/prnh/20131022/PH01403-a) (Logo: http://photos.prnewswire.com/prnh/20131022/PH01403LOGO-b) CureCancerStarter.org, a 501c3 nonprofit, features cancer research from the University of North Carolina Lineberger Comprehensive Cancer Center (Chapel Hill, NC), The Duke...

2013-08-09 09:56:09

Since 2011, the University of North Carolina has partnered with the government of Malawi to establish a pathology laboratory in the nation's capital, building on an existing decades-long collaboration. The laboratory has provided an invaluable service to patients and has also built capacity at a national teaching hospital, according to an analysis of the first 20 months of operation published (date) online by PLOS ONE. "A robust platform for cancer care and research now exists in a setting...

2013-07-10 16:05:41

Different factors influence delay between diagnosis and first course of treatment for breast cancer for African-American and White women. The study used data from the Carolina Breast Cancer Study (CBCS) Phase III, a program of UNC Lineberger Comprehensive Cancer Center. Scientists found that among White women, household size and losing a job due to one's diagnosis were reasons for delay in treatment, while among African-American women, the type of treatment received influenced delay. Both...